Evidence map›Paper›PMID 36416530›Full record

ArticleLangmuir : the ACS journal of surfaces and colloids2022

Characterization of FcγRIa (CD64) as a Ligand Molecule for Site-Specific IgG1 Capture: A Side-By-Side Comparison with Protein A.

Eda Capkin, Hasan Kurt, Busra Gurel, Dilan Bicak, Sibel Akgun Bas, Duygu Emine Daglikoca, Meral Yuce

Abstract read
In one paragraph

Article in Langmuir : the ACS journal of surfaces and colloids, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eda CapkinFaculty of Engineering and Natural Sciences, Sabanci University, Tuzla 34956, Istanbul, Turkey.
Hasan KurtSchool of Engineering and Natural Sciences, Istanbul Medipol University, Beykoz 34810, Istanbul, Turkey.
Busra GurelSUNUM Nanotechnology Research and Application Center, Sabanci University, Tuzla 34956, Istanbul, Turkey.
Dilan BicakILKO ARGEM Biotechnology R&D Center, Pendik 34906, Istanbul, Turkey.
Sibel Akgun BasILKO ARGEM Biotechnology R&D Center, Pendik 34906, Istanbul, Turkey.
Duygu Emine DaglikocaILKO ARGEM Biotechnology R&D Center, Pendik 34906, Istanbul, Turkey.
Meral YuceSUNUM Nanotechnology Research and Application Center, Sabanci University, Tuzla 34956, Istanbul, Turkey.ORCID 0000-0003-0393-1225

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fc γ receptors (FcγRs) are one of the structures that can initiate effector function for monoclonal antibodies. FcγRIa has the highest affinity toward IgG1-type monoclonal antibodies among all FcγRs. In this study, a comprehensive characterization was performed for FcγRIa as a potential affinity ligand for IgG1-type monoclonal antibody binding. The binding interactions were assessed with the SPR technique using different immobilization techniques such as EDC-NHS coupling, streptavidin-biotin interaction, and His-tagged FcγRIa capture. The His-tagged FcγRIa capture was the most convenient method based on assay repeatability. Next, a crude IgG1 sample and its fractions with different monomer contents obtained from protein A affinity chromatography were used to evaluate FcγRIa protein in terms of monoclonal antibody binding capacity. The samples were also compared with a protein A-immobilized chip (a frequently used affinity ligand) for IgG1 binding responses. The antibody binding capacity of the protein A-immobilized chip surface was significantly better than that of the FcγRIa-immobilized chip surface due to its 5 Ig binding domains. The antibody binding responses changed similarly with protein A depending on the monomer content of the sample. Finally, a different configuration was used to assess the binding affinity of free FcγRs (FcγRIa, FcγRIIa, and FcγRIIIa) to three different immobilized IgGs by immobilizing protein L to the chip surface. Unlike previous immobilization techniques tested where the FcγRIa was utilized as a ligand, nonimmobilized or free FcγRIa resulted in a significantly higher antibody binding response than free protein A. In this configuration, kinetics data of FcγRI revealed that the association rate (

Indexed as

Receptors, IgGStaphylococcal Protein AAntibodies, ImmobilizedAntibodies, MonoclonalImmunoglobulin GKineticsLigandsProtein BindingAntibodies, ImmobilizedAntibodies, MonoclonalImmunoglobulin GLigandsReceptors, IgGStaphylococcal Protein A

Identifiers

PMID36416530
PMCPMC9730901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.